Dr. Samreen Sarfaraz, Consultant Infectious Diseases, was the speaker of the first CME of the year 2017. She started her presentation with a simple introduction to Hansen’s Disease also known as Leprosy and that it is closely related to Tuberculosis. She highlighted that Acid-Fast Bacilli (ABF) Smear results in positive for both Tuberculosis and Leprosy but the point of differentiation is growth of the organism, i.e. Mycobacterium leprae does not grow.
Discussing the transmission, she informed that it can occurs through nasal, oral droplets and dermal inoculations. Natural reservoirs include Armadillo, mice, rabbit and some types of monkeys, however, transmission occurs from human to human also. Under the heading of treatment, she discussed about the history acknowledging Dapsone being the first anti-leprotic drug. She also explained the multi-drug therapy currently used to treat Hansen’s Disease.
It was an excellent conference well planned, presented, and well attended. If individually traveling we may have never enjoyed the kind of reception the participants received throughout their stay in Iran.
I want to thank you all for giving me such a great opportunity to be a part of your team (in Haiti). It was a unique experience and I really enjoyed working with you all.
Thank you very much for the wonderful work you do. I have seen it first hand in Karbala during the Arbaeen camps and my son was fortunate to participate in two of the missions. I have made a donation today.
If InshAllah, I secure a residency in the upcoming match, I will owe the organizers and the speakers at the seminar more than they will take credit for.
IMI has been my outlet for philanthropic work since before I entered into high school. It is through IMI that I see my efforts, here in New Jersey, manifest into something much greater around the world. IMI has helped me realize that ambition alone is not enough to change the world; in order to achieve the changes we wish to see in this world we require ambition, vision, and most importantly execution. That is why I have joined IMI, so that my ambition and vision can meet their execution.